Drug and Alcohol Dependence
Volume 88 , Pages S14-S23 , May 2007

Comparing adaptive stepped care and monetary-based voucher interventions for opioid dependence

  • Robert K. Brooner

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, United States
    • Addiction Treatment Services, Johns Hopkins Bayview Medical Center, Baltimore, MD, United States
    • Corresponding Author InformationCorresponding author at: Addiction Treatment Services, Johns Hopkins Behavioral Biology Research Center, Suite 1500, 5510 Nathan Shock Drive, Baltimore, MD 21224, United States. Tel.: +1 410 550 0028; fax: +1 410 550 2957.
    • ,
  • Michael S. Kidorf

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, United States
    • Addiction Treatment Services, Johns Hopkins Bayview Medical Center, Baltimore, MD, United States
    • ,
  • Van L. King

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, United States
    • Addiction Treatment Services, Johns Hopkins Bayview Medical Center, Baltimore, MD, United States
    • ,
  • Kenneth B. Stoller

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, United States
    • Addiction Treatment Services, Johns Hopkins Bayview Medical Center, Baltimore, MD, United States
    • ,
  • Karin J. Neufeld

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, United States
    • Addiction Treatment Services, Johns Hopkins Bayview Medical Center, Baltimore, MD, United States
    • ,
  • Ken Kolodner

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, United States
    • Addiction Treatment Services, Johns Hopkins Bayview Medical Center, Baltimore, MD, United States

Received 3 May 2006 ,Revised 5 December 2006 ,Accepted 12 December 2006.

References 

  1. Avants SK, Margolin A, Sindelar JL, Rounsaville BJ, Schottenfeld R, Stine S, et al. Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost. Am. J. Psychiatr. 1999;156:27–33
  2. Ball JC, Ross A. The Effectiveness of Methadone Maintenance Treatment. New York: Springer-Verlag; 1991;
  3. Brooner RK, Kidorf M. Using behavioral reinforcement to improve methadone treatment participation. Sci. Pract. Perspect. 2002;1:38–46
  4. Brooner RK, Kidorf MS, King VL, Peirce JM, Bigelow GE, Kolodner K. A modified “stepped care” approach to improve attendance behavior in treatment seeking opioid abusers. J. Subst. Abuse Treat. 2004;27:223–232
  5. Brooner RK, Kidorf MS, King VL, Stoller K. Preliminary evidence of good treatment response in antisocial drug abusers. Drug Alcohol Depend. 1998;49:249–260
  6. Brooner RK, King VL, Kidorf M, Schmidt CW, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch. Gen. Psychiatr. 1997;54:71–80
  7. Carroll KM, Nich C, Ball SA, McCance E, Frankforter TL, Rounsaville BJ. One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment. Addiction. 2000;95:1335–1349
  8. Center for Substance Abuse Treatment, 2001. Code of Federal Regulations. Substance Abuse and Mental Health Services Administration, 42 (Part 8).
  9. Davison GC. Stepped care: doing more with less?. J. Consult. Clin. Psychol. 2000;68:580–585
  10. Dolan MP, Black JL, Penk WE, Robinowitz R, DeFord HA. Contracting for treatment termination to reduce illicit drug use among methadone maintenance treatment failures. J. Consult. Clin. Psychol. 1985;53:549–551
  11. Epstein DH, Hawkins WE, Covi L, Preston KL. Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up. Psychol. Addict. Behav. 2003;17:73–82
  12. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis Disorders—Patient Edition (SCID-I/P, Version 2.0). New York: New York State Psychiatric Institute; 1995;
  13. First MB, Spitzer RL, Gibbon M, Williams JBW, Benjamin L. Structured Clinical Interview for DSM-IV Axis II Personality Disorders—Patient Edition (SCID-II, Version 2.0). New York: New York State Psychiatric Institute; 1995;
  14. Haaga DA. Introduction to the special section on stepped care models in psychotherapy. J. Consult. Clin. Psychol. 2000;68:547–548
  15. Higgins S, Delaney DD, Budney AJ, Bickel WK, Hughes JR, Foerg BA, et al. A behavioral approach to achieving initial cocaine abstinence. Am. Psychiatr. 1991;148:1218–1224
  16. Higgins ST, Sigmon SC, Wong CJ, Heil SH, Badger GJ, Donham R, et al. Community reinforcement therapy for cocaine-dependent outpatients. Arch. Gen. Psychiatr. 2003;60:1043–1052
  17. Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. JAMA. 2000;343:1290–1297
  18. Kidorf M, Brooner RK, King VL. Motivating methadone patients to include drug-free significant others in treatment: a behavioral intervention. J. Subst. Abuse Treat. 1997;14:23–28
  19. Kidorf M, Brooner RK, King VL, Stoller KB, Wertz J. Predictive validity of cocaine, sedative, and alcohol dependence diagnoses. J. Consult. Clin. Psychol. 1998;66:168–173
  20. Kidorf M, King VL, Brooner RK. Counseling and psychosocial services. In:  Strain EC,  Stitzer ML editor. The Treatment of Opioid Dependence. Baltimore: Johns Hopkins University Press; 2006;p. 119–150
  21. Kidorf M, Stitzer ML. Contingent access to clinic privileges reduces drug abuse in methadone maintenance patients. In:  Higgins S,  Silverman K editor. Motivating Behavior Change Among Illicit-drug Abusers: Contemporary Research on Contingency Management Interventions. American Psychological Association; 1999;p. 221–242
  22. Kidorf M, Stitzer ML, Brooner RK, Goldberg J. Contingent methadone take-home doses reinforce adjunct therapy attendance of methadone maintenance patients. Drug Alcohol Depend. 1994;36:221–226
  23. Kidorf M, Stitzer ML, Griffiths RR. Evaluating the reinforcement value of clinic-based privileges through a multiple choice procedure. Drug Alcohol Depend. 1995;39:167–172
  24. King VL, Kidorf MS, Stoller KB, Carter JA, Brooner RK. Influence of antisocial personality subtypes on drug abuse treatment response. J. Nerv. Ment. Dis. 2001;189:593–601
  25. Liang KY, Zeger SL. On the use of concordant pairs in matched case-control studies. Biometrics. 1988;44:1145–1156
  26. Magura S, Nwakeze PC, Demsky S. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction. 1998;93:51–60
  27. McLellan AT, Arndt IO, Metzger DS, Woody GE, O’Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA. 1993;269:1953–1959
  28. McLellan AT, Lewis DC, O’Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284:1689–1695
  29. Morral AR, Belding MA, Iguchi MY. Identifying methadone maintenance clients at risk for poor treatment response: pretreatment and early progress indicators. Drug Alcohol Depend. 1999;55:25–33
  30. Murphy S, McKay JR. Adaptive treatment strategies: an emerging approach for improving treatment effectiveness. Clin. Sci. 2004;(Winter–Spring Issue):7–13
  31. Murphy SA, van der Laan MJ, Robins J CPPRG. Marginal mean models for dynamic regimes. J. Am. Stat. Assoc. 2001;96:1410–1423
  32. Newman MG. Recommendations for a cost-offset model of psychotherapy allocation using generalized anxiety disorder as an example. J. Consult. Clin. Psychol. 2000;68:549–555
  33. Peirce JM, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, et al. Lower-cost incentives increase stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch. Gen. Psychiatr. 2006;63:201–208
  34. Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, et al. Prize-based incentives increase retention in outpatient psychosocial treatment programs: a National Drug Abuse Treatment Clinical Trials Network Study. Arch. Gen. Psychiatr. 2005;62:1148–1156
  35. Rawson RA, Huber A, McCann M, Shopaw S, Farabee D, Reiber C, et al. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch. Gen. Psychiatr. 2002;59:817–824
  36. Roll JM, Chudzynski JE, Richardson G. Potential sources of reinforcement and punishment in a drug-free treatment clinic: client and staff perceptions. Am. J. Drug Alcohol Abuse. 2005;1:21–33
  37. Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD. Prognostic significance of psychopathology in treated opiate addicts. Arch. Gen. Psychiatr. 1986;43:739–745
  38. Sigmon SC, Stitzer ML. Use of a low-cost incentive intervention to improve counseling attendance among methadone-maintained patients. J. Subst. Abuse Treat. 2005;29:253–258
  39. Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, Schuster CR, et al. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch. Gen. Psychiatr. 1996;53:409–415
  40. Silverman K, Robles E, Mudric T, Bigelow GE, Stitzer ML. A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs. J. Consult. Clin. Psychol. 2004;72:839–854
  41. Simpson DD, Joe GW, Rowan-Szal GA. Drug abuse treatment retention and process effects on follow-up outcomes. Drug Alcohol Depend. 1997;47:227–235
  42. Simpson DD, Joe GW, Rowan-Szal G, Greener J. Client engagement and change during drug abuse treatment. J. Subst. Abuse. 1995;7:117–134
  43. Sobell MB, Sobell LC. Stepped care as a heuristic approach to the treatment of alcohol problems. J. Consult. Clin. Psychol. 2000;68:573–579
  44. Stitzer ML, Petry N, Silverman K. Contingency management therapies. In:  Strain EC,  Stitzer ML editor. The Treatment of Opioid Dependence. Baltimore: Johns Hopkins University Press; 2006;p. 151–177
  45. Stitzer M, Bigelow G, Lawrence C, Cohen J, D’Lugoff B, Hawthorne J. Medication take-home as a reinforcer in a methadone maintenance program. Addict. Behav. 1977;2:9–14
  46. Strain EC. Methadone dose during maintenance treatment. In:  Strain EC,  Stitzer ML editor. The Treatment of Opioid Dependence. Baltimore: Johns Hopkins University Press; 2006;p. 89–118
  47. Strain EC, Stitzer ML. The Treatment of Opioid Dependence. Baltimore: The Johns Hopkins University Press; 2006;
  48. Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Useful predictors of outcome in methadone-treated patients: results from a controlled clinical trial with three doses of methadone. J. Mainten. Addict. 1998;1:15–28
  49. Wilson GT, Vitousek KM, Loeb KL. Stepped care treatment for eating disorders. J. Consult. Clin. Psychol. 2000;68:564–572
  50. Woody GE, McLellan AT, Luborsky L, O’Brien CP. Sociopathy and psychotherapy outcome. Arch. Gen. Psychiatr. 1985;42:1081–1086
  51. Zeger SL, Liang KY, Albert P. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44:1049–1060

PII: S0376-8716(06)00466-2

doi: 10.1016/j.drugalcdep.2006.12.006

Drug and Alcohol Dependence
Volume 88 , Pages S14-S23 , May 2007

Article Tools

* Image Usage & Resolution